Published in Liver Transpl on January 01, 2001
Liver transplantation for acute hepatic failure due to chemotherapy-induced HBV reactivation in lymphoma patients. World J Gastroenterol (2011) 0.82
Peginterferon alfa-2a in patients with chronic hepatitis C. N Engl J Med (2000) 5.58
Development of a humanized monoclonal antibody (MEDI-493) with potent in vitro and in vivo activity against respiratory syncytial virus. J Infect Dis (1997) 3.88
Pulmonary aspergillosis in the acquired immunodeficiency syndrome. N Engl J Med (1991) 3.69
Compared efficacy of preservation solutions in liver transplantation: a long-term graft outcome study from the European Liver Transplant Registry. Am J Transplant (2015) 2.71
Analysis of factors predictive of mortality in alcoholic hepatitis and derivation and validation of the Glasgow alcoholic hepatitis score. Gut (2005) 2.62
Amylase-resistant starch plus oral rehydration solution for cholera. N Engl J Med (2000) 2.41
The human liver contains multiple populations of NK cells, T cells, and CD3+CD56+ natural T cells with distinct cytotoxic activities and Th1, Th2, and Th0 cytokine secretion patterns. J Immunol (1999) 2.39
Cold plasma selectivity and the possibility of a paradigm shift in cancer therapy. Br J Cancer (2011) 2.39
Epstein-Barr virus-associated Hodgkin's disease: epidemiologic characteristics in international data. Int J Cancer (1997) 2.30
Selection of patients for liver transplantation and allocation of donated livers in the UK. Gut (2007) 2.20
Professional athletes suffering from familial hypercholesterolaemia rarely tolerate statin treatment because of muscular problems. Br J Clin Pharmacol (2004) 2.18
Normalised intrinsic mortality risk in liver transplantation: European Liver Transplant Registry study. Lancet (2000) 1.99
Regional specificity of brain glucocorticoid receptor mRNA alterations in subjects with schizophrenia and mood disorders. Mol Psychiatry (2002) 1.81
Functional polymorphisms in the interleukin-6 and serotonin transporter genes, and depression and fatigue induced by interferon-alpha and ribavirin treatment. Mol Psychiatry (2008) 1.80
p53 expression in colorectal tumors. Am J Pathol (1991) 1.77
Sclerosing encapsulating peritonitis after orthotopic liver transplantation. Am J Surg (2001) 1.74
Clinical guidelines on the management of hepatitis C. Gut (2001) 1.72
Evidence for an immune response to HLA class I antigens in the vanishing-bileduct syndrome after liver transplantation. Lancet (1987) 1.68
A double blind placebo controlled crossover study of prostacyclin in man. Life Sci (1979) 1.67
N-acetylcysteine improves indocyanine green extraction and oxygen transport during hepatic dysfunction. Crit Care Med (1997) 1.62
Motivational aspects of deliberate self-poisoning in adolescents. Br J Psychiatry (1982) 1.62
A functional polymorphism of the stromelysin gene (MMP-3) influences susceptibility to primary sclerosing cholangitis. Gastroenterology (2001) 1.60
Adolescents who take overdoses: their characteristics, problems and contacts with helping agencies. Br J Psychiatry (1982) 1.59
Review article: optimizing SVR and management of the haematological side effects of peginterferon/ribavirin antiviral therapy for HCV - the role of epoetin, G-CSF and novel agents. Aliment Pharmacol Ther (2010) 1.58
Ocular malaria. A clinical and histopathologic study. Ophthalmology (1996) 1.57
Valganciclovir results in improved oral absorption of ganciclovir in liver transplant recipients. Antimicrob Agents Chemother (2000) 1.50
Impact of human immunodeficiency virus (HIV) infection on the progression of liver fibrosis in hepatitis C virus infected patients. Gut (2003) 1.48
Side effects occurring during administration of epoprostenol (prostacyclin, PGI2), in man. Br J Clin Pharmacol (1982) 1.48
Use and outcome of liver transplantation in acetaminophen-induced acute liver failure. Hepatology (1998) 1.48
Improved survival in liver transplant recipients receiving prolonged-release tacrolimus in the European Liver Transplant Registry. Am J Transplant (2015) 1.46
Curative hepatorenal transplantation in systemic amyloidosis caused by the Glu526Val fibrinogen alpha-chain variant in an English family. QJM (2000) 1.45
Liver and intestinal lactate metabolism in patients with acute hepatic failure undergoing liver transplantation. Crit Care Med (2001) 1.45
Hepatitis B virus resistance to adefovir in a nucleotide naive patient with chronic hepatitis B virus infection. J Antimicrob Chemother (2007) 1.44
Platelet lipoxygenase defect (Wien-Penzing defect) in two patients with myocardial infarction. Am J Hematol (1991) 1.43
Osteonecrosis of the jaw complicating bisphosphonate treatment for bone disease in multiple myeloma: an overview with recommendations for prevention and treatment. Intern Med J (2008) 1.43
Studies on the growth, optical, electrical and spectral properties of potassium pentaborate (KB5) single crystals. Spectrochim Acta A Mol Biomol Spectrosc (2007) 1.40
Size reduction of small bowels from adult cadaveric donors to alleviate the scarcity of pediatric size-matched organs: an anatomical and feasibility study. Transplantation (2000) 1.39
Abdominal organ donation after death. Br J Surg (2011) 1.39
Development of in vitro correlate assays of immunity to infection with Yersinia pestis. Clin Vaccine Immunol (2007) 1.37
Noninvasive assessment of the cardiovascular effects of prostacyclin (PGI2) in man. Eur J Cardiol (1980) 1.36
Progressive cardiac amyloidosis following liver transplantation for familial amyloid polyneuropathy: implications for amyloid fibrillogenesis. Transplantation (1998) 1.35
Stenoses of vascular anastomoses after hepatic transplantation: treatment with balloon angioplasty. AJR Am J Roentgenol (1991) 1.34
Inter-laboratory comparison of the CD-1 neonatal mouse logistic dose-response model for Cryptosporidium parvum oocysts. J Eukaryot Microbiol (2000) 1.32
Hepatic artery pseudoaneurysms following liver transplantation: incidence, presenting features and management. Clin Radiol (2001) 1.32
Hydrodynamic gene delivery to the pig liver via an isolated segment of the inferior vena cava. Gene Ther (2007) 1.31
De-novo autoimmune hepatitis after liver transplantation. Lancet (1998) 1.30
Effects of intravenous infusion of prostacyclin (PGI2) in man. Prostaglandins (1980) 1.30
The 'small for size' liver syndrome. Curr Opin Crit Care (2005) 1.28
Historical epidemiology of hepatitis C virus (HCV) in select countries - volume 2. J Viral Hepat (2015) 1.22
Quality of life after liver transplantation for alcoholic liver disease. Liver Transpl (2000) 1.21
Experience of orthotopic liver transplantation and hepatic resection for hepatocellular carcinoma of less than 8 cm in patients with cirrhosis. Br J Surg (1995) 1.20
Unusual localizations of hydatid disease: a 18 year experience. G Chir (1994) 1.16
Hepatitis C and HIV-1 coinfection. Gut (2002) 1.12
Split liver transplantation: King's College Hospital experience. Ann Surg (1998) 1.12
Guidelines for referral to a regional genetics service: GPs respond by referring more appropriate cases. Fam Pract (2001) 1.11
Nitric oxide generation. A predictive parameter of acute allograft rejection. Transplantation (1994) 1.11
Differentiation between infection in kidney and liver cysts in autosomal dominant polycystic kidney disease: use of PET-CT in diagnosis and to guide management. Transplant Proc (2009) 1.11
The Glasgow alcoholic hepatitis score identifies patients who may benefit from corticosteroids. Gut (2007) 1.11
Use of infrarenal conduits for arterial revascularization in orthotopic liver transplantation. Liver Transpl Surg (1998) 1.10
Hepatic artery resistance index can predict early death in children with biliary atresia. Liver Transpl Surg (1997) 1.10
A phase I trial of immunosuppression with anti-ICAM-1 (CD54) mAb in renal allograft recipients. Transplantation (1993) 1.10
Aspirin: A paradoxical effect on bleeding-time. Lancet (1978) 1.08
Hyperacute rejection in liver transplantation: a case report. Transplant Proc (1989) 1.07
Isolation of lymphocytes from normal adult human liver suitable for phenotypic and functional characterization. J Immunol Methods (2000) 1.07
Late onset hepatic failure: clinical, serological and histological features. Hepatology (1986) 1.06
Extremely-low-dose aspirin (1 mg per day) renders human platelets more sensitive to antiaggregation prostaglandins. N Engl J Med (1984) 1.05
An in vitro larval motility assay to determine anthelmintic sensitivity for human hookworm and Strongyloides species. Am J Trop Med Hyg (2004) 1.05
Psychopathological symptoms during interferon-alpha and ribavirin treatment: effects on virologic response. Mol Psychiatry (2005) 1.05
A modified larval migration assay for detection of resistance to macrocyclic lactones in Haemonchus contortus, and drug screening with Trichostrongylidae parasites. Vet Parasitol (2006) 1.04
Renal glucose production compensates for the liver during the anhepatic phase of liver transplantation. Diabetes (2000) 1.03
Prediction of stroke volume from oxygen pulse measurements in untrained and trained men. Can J Appl Physiol (1994) 1.03
The present and future disease burden of hepatitis C virus (HCV) infections with today's treatment paradigm - volume 2. J Viral Hepat (2015) 1.02
Isolation of Corynebacterium striatum from three hospital patients. Eur J Clin Microbiol Infect Dis (1994) 1.02
Should we retransplant a patient who is non-adherent? A literature review and critical reflection. Pediatr Transplant (2012) 1.00
Coherent exciton-surface-plasmon-polariton interaction in hybrid metal-semiconductor nanostructures. Phys Rev Lett (2008) 1.00
Development of a reliable and valid nutritional knowledge questionnaire for urban South African adolescents. Nutrition (2005) 1.00
Laparoscopic cholecystectomy injury: an unusual indication for liver transplantation. Transpl Int (1998) 1.00
Epidemiology, bacteriology and control of an outbreak of Nocardia asteroides infection on a liver unit. J Hosp Infect (1991) 0.99
Scale-up of TB and HIV programme collaborative activities in Zambia - a 10-year review. Trop Med Int Health (2012) 0.99
Effects of pseudoephedrine and triprolidine, alone and in combination, on symptoms of the common cold. Br Med J (1980) 0.99
Demonstration of Leishmania specific cell mediated and humoral immunity in asymptomatic dogs. Parasite Immunol (1992) 0.98
A prospective randomised trial of bile duct reconstruction at liver transplantation: T tube or no T tube? Transpl Int (1996) 0.98
Two different types of exercise-induced muscle pain without myopathy and CK-elevation during HMG-Co-enzyme-A-reductase inhibitor treatment. Atherosclerosis (1999) 0.97